Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial

Q Qihua Zou S Shenrui Bai L Liang Wang H Hongyan Tong D Dongfeng Zeng Y Ying Zhao (Division of Biobased Chemicals) Y Yuerong Shuang X Xiaobo Wang X Xiuhua Sun Z Zhenya Hong Z Zhigang Peng Y Yu Yang R Runhui Zheng H Huiqiang Huang J Jianbo Liu C Chunmei Yang X Xi Li (State Key Laboratory of Functional Materials for Informatics, Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai, China.) X Xin Gao H Hao Xu D Daoguang Chen X Xiaojie Fang M Man Nie J Jinni Wang X Xinna Gao J Jingjing Ye W Wei Zhang J Jianzhen Shen R Rong Tao H Hong Cen Y YuChen Zhang J Jun Cai (School of Physical Science and Technology) Y Yi Xia Q Qingqing Cai